The store will not work correctly when cookies are disabled.
ID: ALA4293825
Max Phase: Preclinical
Molecular Formula: C14H9NO6S2
Molecular Weight: 351.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=c1ccoc2c3c(cc(NS(=O)(=O)c4cccs4)c12)OCO3
Standard InChI: InChI=1S/C14H9NO6S2/c16-9-3-4-19-14-12(9)8(6-10-13(14)21-7-20-10)15-23(17,18)11-2-1-5-22-11/h1-6,15H,7H2
Standard InChI Key: SAGSAESMVBMFHH-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 351.36 | Molecular Weight (Monoisotopic): 350.9871 | AlogP: 2.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 94.84 | Molecular Species: ACID | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 5.85 | CX Basic pKa: | CX LogP: 1.73 | CX LogD: 0.87 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.78 | Np Likeness Score: -0.92 |
References
1. (2016) Compounds, compositions and methods for inhibiting cnksr1, |
2. (2016) Compounds, compositions and methods for inhibiting cnksr1, |